GSEP
HURA

Golden State Equity Partners’s TuHURA Biosciences HURA Stock Holding History

Golden State Equity Partners’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-37
Closed -$55K – 267
2021
Q3 		$55K Sell
37
-4
-10% -$10.5K 0.02% 231
2021
Q2 		$162K Buy
+41
New +$118K 0.06% 237
2021
Q1 		– Sell
-6
Closed -$14K – 226
2020
Q4 		$14K Buy
+6
New +$15K 0.01% 184

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Golden State Equity Partners's HURA Position: Q4 2021 in Review

Golden State Equity Partners sold out of TuHURA Biosciences (HURA) in Q4 2021, closing a stake of 37 shares — an estimated $55K sold.

Golden State Equity Partners first reported a position in HURA in Q4 2020 and held it in 3 quarters. The position peaked at $162K in Q2 2021. 24 funds tracked by Wall St. Rank hold HURA as of Q4 2021.

  • Golden State Equity Partners reported no remaining TuHURA Biosciences position as of Q4 2021 after selling out during the quarter.
  • Golden State Equity Partners sold 37 TuHURA Biosciences shares in Q4 2021, an estimated $55K.
  • Golden State Equity Partners first reported a position in TuHURA Biosciences in Q4 2020 and held it in 3 quarters.
  • Golden State Equity Partners's TuHURA Biosciences position peaked at $162K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2021.

Based on Golden State Equity Partners's 13F filing for Q4 2021, filed 11 Feb 2022.